A 52-year-old man with no history of cardiovascular disease is seen in primary care. He is a non-smoker with well-controlled hypertension and LDL-C 3.8 mmol/L. His calculated 10-year ASCVD risk is 18 percent. According to the 2021 Canadian Cardiovascular Society dyslipidaemia guidelines, what is the most appropriate lipid-lowering strategy?